Skip to main content
. 2021 Jun 29;178(18):3747–3764. doi: 10.1111/bph.15515

FIGURE 2.

FIGURE 2

Body weight in CTEP‐ and vehicle‐treated SOD1G93A and WT mice. The body weight loss was measured as an index of disease progression in CTEP‐ and vehicle‐treated SOD1G93A or WT male and female mice, at low‐dose (2 mg·kg−1 every 48 h) or high‐dose (4 mg·kg−1 every 24 h) CTEP. Animals were weighed 3 days a week starting on Day 80 of life. Data in (a) are means ± SEM of 15 low‐dose CTEP‐treated and 15 vehicle‐treated SOD1G93A male mice and of five low‐dose CTEP‐treated and five vehicle‐treated WT male mice. Data in (b) are means ± SEM of 15 low‐dose CTEP‐treated and 11 vehicle‐treated SOD1G93A female mice and of five low‐dose CTEP‐treated and five vehicle‐treated WT female mice. Data in (c) are means ± SEM of 14 high‐dose CTEP‐treated and 14 vehicle‐treated SOD1G93A male mice and five high‐dose CTEP‐treated and five vehicle‐treated WT male mice. Data in (d) are means ± SEM of 12 high‐dose CTEP‐treated and 11 vehicle‐treated SOD1G93A female mice and five high‐dose CTEP‐treated and five vehicle‐treated WT female mice. *P < 0.05, significantly different from CTEP‐ or vehicle‐treated WT mice, respectively; # P < 0.05, significantly different from vehicle‐treated SOD1G93A mice; two‐way ANOVA followed by Tukey's post hoc test